131 related articles for article (PubMed ID: 12610740)
21. Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.
Arlander E; Sjövall J; Sörstad J; Norsten-Höög C; Gustafsson LL
Br J Clin Pharmacol; 2003 Jan; 55(1):14-22. PubMed ID: 12534636
[TBL] [Abstract][Full Text] [Related]
22. Ropivacaine pharmacokinetics after caudal block in 1-8 year old children.
Lönnqvist PA; Westrin P; Larsson BA; Olsson GL; Lybeck A; Huledal G; Bielenstein M
Br J Anaesth; 2000 Oct; 85(4):506-11. PubMed ID: 11064606
[TBL] [Abstract][Full Text] [Related]
23. Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep.
Ratajczak-Enselme M; Estebe JP; Rose FX; Wodey E; Malinovsky JM; Chevanne F; Dollo G; Ecoffey C; Le Corre P
Br J Anaesth; 2007 Dec; 99(6):881-90. PubMed ID: 17959589
[TBL] [Abstract][Full Text] [Related]
24. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
Isohanni MH; Neuvonen PJ; Olkkola KT
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):168-72. PubMed ID: 16918719
[TBL] [Abstract][Full Text] [Related]
25. Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites.
Arvidsson T; Askemark Y; Halldin MM
Biomed Chromatogr; 1999 Jun; 13(4):286-92. PubMed ID: 10416062
[TBL] [Abstract][Full Text] [Related]
26. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers.
Knudsen K; Beckman Suurküla M; Blomberg S; Sjövall J; Edvardsson N
Br J Anaesth; 1997 May; 78(5):507-14. PubMed ID: 9175963
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of 0.75% ropivacaine and 0.5% bupivacaine after ilioinguinal-iliohypogastric nerve block in children.
Ala-Kokko TI; Karinen J; Räihä E; Kiviluoma K; Alahuhta S
Br J Anaesth; 2002 Sep; 89(3):438-41. PubMed ID: 12402722
[TBL] [Abstract][Full Text] [Related]
28. Effect of propofol on ropivacaine metabolism in human liver microsomes.
Osaka Y; Inomata S; Tanaka E; Nakamura T; Honda K; Miyabe M; Toyooka H; Tanaka M
J Anesth; 2006; 20(1):60-3. PubMed ID: 16421682
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study.
Cuvillon P; Nouvellon E; Ripart J; Boyer JC; Dehour L; Mahamat A; L'hermite J; Boisson C; Vialles N; Lefrant JY; de La Coussaye JE
Anesth Analg; 2009 Feb; 108(2):641-9. PubMed ID: 19151302
[TBL] [Abstract][Full Text] [Related]
30. Liquid chromatographic determination of plasma ropivacaine for assessing pharmacokinetics of the viscous preparation.
Kawata T; Homma M; Kakiuchi Y; Inomata S; Miyabe M; Kobayashi D; Morimoto Y; Kohda Y
Biol Pharm Bull; 2005 Dec; 28(12):2271-3. PubMed ID: 16327164
[TBL] [Abstract][Full Text] [Related]
31. High-performance liquid chromatography using UV detection for the simultaneous quantification of ropivacaine and bupivacaine in human plasma.
Gaudreault F; Drolet P; Varin F
Ther Drug Monit; 2009 Dec; 31(6):753-7. PubMed ID: 19809388
[TBL] [Abstract][Full Text] [Related]
32. A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic-Pharmacodynamic Studies After Subcutaneous Administration in Pigs.
Davidson EM; Haroutounian S; Kagan L; Naveh M; Aharon A; Ginosar Y
Anesth Analg; 2016 May; 122(5):1663-72. PubMed ID: 27057797
[TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic.
Arthur GR; Feldman HS; Covino BG
Anesth Analg; 1988 Nov; 67(11):1053-8. PubMed ID: 3189894
[TBL] [Abstract][Full Text] [Related]
34. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A.
Gantenbein M; Attolini L; Bruguerolle B; Villard PH; Puyoou F; Durand A; Lacarelle B; Hardwigsen J; Le-Treut YP
Drug Metab Dispos; 2000 Apr; 28(4):383-5. PubMed ID: 10725304
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
[TBL] [Abstract][Full Text] [Related]
36. Stable plasma concentrations of unbound ropivacaine during postoperative epidural infusion for 24-72 hours in children.
Berde CB; Yaster M; Meretoja O; McCann ME; Huledal G; Gustafsson U; Larsson LE
Eur J Anaesthesiol; 2008 May; 25(5):410-7. PubMed ID: 18205962
[TBL] [Abstract][Full Text] [Related]
37. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.
Batty KT; Davis TM; Ilett KF; Dusci LJ; Langton SR
Br J Clin Pharmacol; 1995 Mar; 39(3):305-11. PubMed ID: 7619673
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers.
Shahzadi A; Javed I; Aslam B; Muhammad F; Asi MR; Ashraf MY; Zia-ur-Rahman
Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921
[TBL] [Abstract][Full Text] [Related]
39. Effect of itraconazole on the pharmacokinetics of bupivacaine enantiomers in healthy volunteers.
Palkama VJ; Neuvonen PJ; Olkkola KT
Br J Anaesth; 1999 Oct; 83(4):659-61. PubMed ID: 10673888
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects and regional clearances of intravenous ropivacaine in sheep.
Rutten AJ; Mather LE; Nancarrow C; Sloan PA; McLean CF
Anesth Analg; 1990 Jun; 70(6):577-82. PubMed ID: 2344052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]